Cameron O. Scarlett

1.3k total citations
30 papers, 1.0k citations indexed

About

Cameron O. Scarlett is a scholar working on Molecular Biology, Genetics and Spectroscopy. According to data from OpenAlex, Cameron O. Scarlett has authored 30 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 6 papers in Genetics and 5 papers in Spectroscopy. Recurrent topics in Cameron O. Scarlett's work include Mass Spectrometry Techniques and Applications (5 papers), Estrogen and related hormone effects (4 papers) and Metabolomics and Mass Spectrometry Studies (3 papers). Cameron O. Scarlett is often cited by papers focused on Mass Spectrometry Techniques and Applications (5 papers), Estrogen and related hormone effects (4 papers) and Metabolomics and Mass Spectrometry Studies (3 papers). Cameron O. Scarlett collaborates with scholars based in United States, Canada and Malaysia. Cameron O. Scarlett's co-authors include Nihal Ahmad, Minakshi Nihal, Howard H. Bailey, Jeremy J. Johnson, Imtiaz A. Siddiqui, Hasan Mukhtar, Diane M. Robins, Christoph H. Borchers, Carol E. Parker and Steven H. Zeisel and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Biochemistry.

In The Last Decade

Cameron O. Scarlett

28 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cameron O. Scarlett United States 17 491 135 125 113 94 30 1.0k
Joong‐Youn Shim United States 17 786 1.6× 210 1.6× 36 0.3× 44 0.4× 74 0.8× 37 1.6k
Yi-Fang Li China 24 517 1.1× 49 0.4× 60 0.5× 116 1.0× 133 1.4× 69 1.4k
Ayako Furukawa Japan 21 678 1.4× 41 0.3× 82 0.7× 22 0.2× 226 2.4× 63 1.5k
Zhen‐Lun Gu China 26 794 1.6× 171 1.3× 49 0.4× 140 1.2× 211 2.2× 79 1.7k
Sharda P. Singh United States 24 1.3k 2.5× 144 1.1× 24 0.2× 135 1.2× 258 2.7× 67 2.1k
Chunsong Yang United States 21 875 1.8× 157 1.2× 25 0.2× 381 3.4× 71 0.8× 38 1.6k
Federica Gilardi Switzerland 27 972 2.0× 114 0.8× 53 0.4× 62 0.5× 470 5.0× 59 1.9k
Yong‐Moon Lee South Korea 19 549 1.1× 74 0.5× 13 0.1× 108 1.0× 69 0.7× 85 1.2k
Clint D.J. Tavares United States 18 1.1k 2.1× 71 0.5× 33 0.3× 38 0.3× 273 2.9× 24 1.6k

Countries citing papers authored by Cameron O. Scarlett

Since Specialization
Citations

This map shows the geographic impact of Cameron O. Scarlett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cameron O. Scarlett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cameron O. Scarlett more than expected).

Fields of papers citing papers by Cameron O. Scarlett

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cameron O. Scarlett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cameron O. Scarlett. The network helps show where Cameron O. Scarlett may publish in the future.

Co-authorship network of co-authors of Cameron O. Scarlett

This figure shows the co-authorship network connecting the top 25 collaborators of Cameron O. Scarlett. A scholar is included among the top collaborators of Cameron O. Scarlett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cameron O. Scarlett. Cameron O. Scarlett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Scarlett, Cameron O., et al.. (2025). Pharmacokinetics of 7,8-dihydroxyflavone in neonatal mice with hypoxia-ischemia related brain injury. Frontiers in Pharmacology. 15. 1508696–1508696.
3.
Westmark, Pamela R., G. Marshall Lyon, Alejandra Gutierrez, et al.. (2024). Effects of Soy Protein Isolate on Fragile X Phenotypes in Mice. Nutrients. 16(2). 284–284. 3 indexed citations
4.
Jones, N., et al.. (2024). Novel extended-release transdermal formulations of the psychedelic N,N-dimethyltryptamine (DMT). European Journal of Pharmaceutical Sciences. 199. 106803–106803. 2 indexed citations
5.
Bailey, Howard H., Cameron O. Scarlett, Thomas C. Havighurst, et al.. (2024). Phase II Clinical Chemoprevention Trial of Weekly Erlotinib before Bladder Cancer Surgery. Cancer Prevention Research. 18(1). 31–39. 1 indexed citations
6.
Jones, N., et al.. (2024). In vivo validation of psilacetin as a prodrug yielding modestly lower peripheral psilocin exposure than psilocybin. Frontiers in Psychiatry. 14. 1303365–1303365. 6 indexed citations
7.
Scarlett, Cameron O., et al.. (2023). Pharmacokinetic analysis of acute and dietary exposure to piperonyl butoxide in the mouse. Toxicology Reports. 11. 310–317. 1 indexed citations
8.
Seok, Seung‐Hyeon, Zhi‐Xiong Ma, John B. Feltenberger, et al.. (2017). Trace derivatives of kynurenine potently activate the aryl hydrocarbon receptor (AHR). Journal of Biological Chemistry. 293(6). 1994–2005. 122 indexed citations
9.
Pei, Ruisong, Diana M DiMarco, Derek Martin, et al.. (2017). Low-fat yogurt consumption reduces biomarkers of chronic inflammation and inhibits markers of endotoxin exposure in healthy premenopausal women: a randomised controlled trial. British Journal Of Nutrition. 118(12). 1043–1051. 57 indexed citations
10.
Gemperline, Erin, et al.. (2014). Measurement of NMDA receptor antagonist, CPP, in mouse plasma and brain tissue following systemic administration using ion-pair LC-MS/MS. Analytical Methods. 6(16). 6389–6396. 4 indexed citations
11.
Ma, Di, Arvinder Kapur, Mildred Felder, et al.. (2013). Differential expression of proteins in naïve and IL-2 stimulated primary human NK cells identified by global proteomic analysis. Journal of Proteomics. 91. 151–163. 15 indexed citations
12.
Johnson, Jeremy J., Minakshi Nihal, Imtiaz A. Siddiqui, et al.. (2011). Enhancing the bioavailability of resveratrol by combining it with piperine. Molecular Nutrition & Food Research. 55(8). 1169–1176. 278 indexed citations
13.
Nikolaishvili‐Feinberg, Nana, Kathleen R. Nevis, Dean P. Staus, et al.. (2008). Ubiquitylation of Proliferating Cell Nuclear Antigen and Recruitment of Human DNA Polymerase η. Biochemistry. 47(13). 4141–4150. 16 indexed citations
14.
Han, Jun, Ryan M. Danell, Jayanti R. Patel, et al.. (2008). Towards high-throughput metabolomics using ultrahigh-field Fourier transform ion cyclotron resonance mass spectrometry. Metabolomics. 4(2). 128–140. 114 indexed citations
15.
Boysen, Gunnar, Cameron O. Scarlett, Brenda Temple, et al.. (2007). Identification of covalent modifications in P450 2E1 by 1,2-epoxy-3-butene in vitro. Chemico-Biological Interactions. 166(1-3). 170–175. 14 indexed citations
16.
Bell, Timothy A., et al.. (2007). Three male germline-specific aldolase A isozymes are generated by alternative splicing and retrotransposition. Developmental Biology. 309(1). 18–31. 45 indexed citations
17.
Thelin, William R., Yun Chen, Martina Gentzsch, et al.. (2007). Direct interaction with filamins modulates the stability and plasma membrane expression of CFTR. Journal of Clinical Investigation. 117(2). 364–374. 80 indexed citations
18.
Parker, Carol E., et al.. (2005). Identification of Components of Protein Complexes. Humana Press eBooks. 301. 117–152. 37 indexed citations
19.
Scarlett, Cameron O.. (2003). Neuroanatomical development in the absence of PKC phosphorylation of the myristoylated alanine-rich C-kinase substrate (MARCKS) protein. Developmental Brain Research. 144(1). 25–42. 15 indexed citations
20.
Scarlett, Cameron O., et al.. (1997). Involvement of an Octamer-Like Sequence Within a Crucial Region of the Androgen-Dependent Slp Enhancer. DNA and Cell Biology. 16(1). 45–57. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026